James Quigley
Stock Analyst at Goldman Sachs
(0.25)
# 4,544
Out of 5,010 analysts
292
Total ratings
42.4%
Success rate
-6.6%
Average return
Main Sectors:
Stocks Rated by James Quigley
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SWX: NOVN Novartis AG | Reiterated: Sell | CHF 113.00 → CHF 110.00 | CHF 121.40 | -9.39% | 28 | Sep 22, 2026 | |
| SWX: ROP Roche Holding AG | Reiterated: Hold | CHF 348.00 → CHF 366.00 | CHF 355.40 | +2.98% | 27 | Sep 15, 2026 | |
| NVO Novo Nordisk | Reiterated: Hold | $47 → $44 | $38.71 | +13.67% | 10 | Aug 6, 2026 | |
| ETR: BAYN Bayer Aktiengesellschaft | Reiterated: Buy | €62.50 → €63.50 | €50.80 | +25.00% | 61 | Aug 5, 2026 | |
| ETR: SRT3 Sartorius Aktiengesellschaft | Reiterated: Hold | €229.00 → €190.00 | €263.50 | -27.89% | 31 | Jul 24, 2026 | |
| SWX: LONN Lonza Group AG | Reiterated: Buy | CHF 670.00 → CHF 680.00 | CHF 584.20 | +16.40% | 22 | Jul 23, 2026 | |
| EPA: SAN Sanofi | Reiterated: Hold | €89.00 → €84.00 | €72.00 | +16.67% | 10 | Jul 6, 2026 | |
| EPA: DIM Sartorius Stedim Biotech S.A. | Reiterated: Buy | €214.00 | €216.60 | -1.20% | 23 | Apr 23, 2026 | |
| ETR: MRK Merck KGaA | Reiterated: Buy | €153.00 → €147.00 | €138.45 | +6.18% | 43 | Apr 16, 2026 | |
| RHHBY Roche Holding AG | Upgraded: Hold | n/a | $53.37 | - | 1 | Jan 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $121 → $118 | $146.88 | n/a | 3 | Sep 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $827.50 | n/a | 1 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $65 → $60 | $41.18 | n/a | 2 | Jul 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | 15,200p | 12,492p | n/a | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €13.00 → €10.50 | €0.75 | n/a | 2 | Oct 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | CHF 65.00 → CHF 64.00 | CHF 81.95 | n/a | 2 | Sep 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | CHF 38.00 → CHF 21.00 | CHF 44.10 | n/a | 5 | Sep 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €27.00 → €28.00 | €2.86 | n/a | 10 | Sep 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €38.00 → €36.00 | €25.98 | n/a | 2 | Sep 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $15 | $1.59 | n/a | 5 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $140 → $205 | $29.84 | n/a | 2 | Jan 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $35.36 | n/a | 1 | Jun 20, 2018 |
Novartis AG
Sep 22, 2026
Reiterated: Sell
Price Target: CHF 113.00 → CHF 110.00
Current: CHF 121.40
Upside: -9.39%
Roche Holding AG
Sep 15, 2026
Reiterated: Hold
Price Target: CHF 348.00 → CHF 366.00
Current: CHF 355.40
Upside: +2.98%
Novo Nordisk
Aug 6, 2026
Reiterated: Hold
Price Target: $47 → $44
Current: $38.71
Upside: +13.67%
Bayer Aktiengesellschaft
Aug 5, 2026
Reiterated: Buy
Price Target: €62.50 → €63.50
Current: €50.80
Upside: +25.00%
Sartorius Aktiengesellschaft
Jul 24, 2026
Reiterated: Hold
Price Target: €229.00 → €190.00
Current: €263.50
Upside: -27.89%
Lonza Group AG
Jul 23, 2026
Reiterated: Buy
Price Target: CHF 670.00 → CHF 680.00
Current: CHF 584.20
Upside: +16.40%
Sanofi
Jul 6, 2026
Reiterated: Hold
Price Target: €89.00 → €84.00
Current: €72.00
Upside: +16.67%
Sartorius Stedim Biotech S.A.
Apr 23, 2026
Reiterated: Buy
Price Target: €214.00
Current: €216.60
Upside: -1.20%
Merck KGaA
Apr 16, 2026
Reiterated: Buy
Price Target: €153.00 → €147.00
Current: €138.45
Upside: +6.18%
Roche Holding AG
Jan 15, 2026
Upgraded: Hold
Price Target: n/a
Current: $53.37
Upside: -
Sep 12, 2025
Downgraded: Sell
Price Target: $121 → $118
Current: $146.88
Upside: n/a
Jul 30, 2025
Reiterated: Hold
Price Target: n/a
Current: $827.50
Upside: n/a
Jul 3, 2025
Reiterated: Hold
Price Target: $65 → $60
Current: $41.18
Upside: n/a
May 30, 2024
Initiated Coverage: Buy
Price Target: 15,200p
Current: 12,492p
Upside: n/a
Oct 10, 2023
Reiterated: Hold
Price Target: €13.00 → €10.50
Current: €0.75
Upside: n/a
Sep 25, 2023
Reiterated: Sell
Price Target: CHF 65.00 → CHF 64.00
Current: CHF 81.95
Upside: n/a
Sep 25, 2023
Reiterated: Hold
Price Target: CHF 38.00 → CHF 21.00
Current: CHF 44.10
Upside: n/a
Sep 25, 2023
Reiterated: Buy
Price Target: €27.00 → €28.00
Current: €2.86
Upside: n/a
Sep 5, 2023
Reiterated: Hold
Price Target: €38.00 → €36.00
Current: €25.98
Upside: n/a
Aug 8, 2023
Reiterated: Buy
Price Target: $16 → $15
Current: $1.59
Upside: n/a
Jan 5, 2020
Downgraded: Hold
Price Target: $140 → $205
Current: $29.84
Upside: n/a
Jun 20, 2018
Upgraded: Buy
Price Target: n/a
Current: $35.36
Upside: n/a